background
nucleic
acid
amplif
assay
becom
method
choic
influenza
flu
test
due
superior
accuraci
faster
turnaround
time
although
assay
design
detect
highli
conserv
genom
target
mutat
influenc
test
sensit
circul
virus
unit
state
season
associ
signific
genet
drift
howev
effect
test
unknown
object
studi
design
compar
perform
prodess
profluprofast
pflupfast
filmarray
respiratori
panel
rp
coba
influenza
ab
test
ciab
xpert
flu
xpt
retrospect
analysi
consecut
nasopharyng
specimen
receiv
twoweek
period
winter
furthermor
limit
detect
lod
determin
six
isol
flu
result
specimen
posit
flua
pfast
posit
rp
posit
ciab
posit
xpt
subset
specimen
test
pflu
posit
sensitivityspecif
pfast
rp
ciab
xpt
pflu
respect
lod
analys
demonstr
assay
perform
variat
strain
associ
specif
pflu
ciab
lod
higher
aswitzerland
strain
xpt
highest
lod
swiss
strain
conclus
strainassoci
assay
perform
variat
known
occur
flu
test
method
henc
surpris
variat
would
observ
molecular
test
care
monitor
report
strainassoci
varianc
warrant
test
method
http
dx
flua
b
import
human
pathogen
infect
hundr
million
peopl
annual
death
worldwid
rapid
identif
import
therapeut
infect
control
purpos
tradit
rapid
diagnost
immunoassay
produc
quick
result
simpl
perform
suboptim
sensit
nucleic
acid
amplif
assay
naat
rel
rapid
greatli
enhanc
sensit
becom
method
choic
naat
design
detect
highli
conserv
genom
target
gener
matrix
protein
mp
gene
howev
mutat
influenc
test
sensit
inde
flu
virus
mutat
evolv
rapidli
continu
antigenet
drift
associ
annual
epidem
need
annual
assess
viral
vaccin
strain
continu
chang
also
associ
annual
chang
sensit
mani
rapid
immunoassay
well
cell
cultur
term
celllin
permiss
although
mutat
rate
ha
na
gene
usual
higher
intern
protein
period
mutat
rate
mp
gene
rival
surfac
protein
inde
problemat
gene
mutat
affect
perform
commerci
assay
observ
virus
recent
mutat
mp
gene
strain
report
taiwan
belgium
major
circul
flua
unit
state
usa
associ
signific
genet
drift
loss
vaccin
protect
reduc
abil
cultur
mani
cell
line
effect
drift
molecular
test
warrant
investig
assess
perform
varieti
molecular
assay
strain
flua
associ
genet
drift
earli
clinic
specimen
initi
compris
consecut
np
specimen
viral
transport
media
vtm
remel
lenexa
ks
receiv
detect
respiratori
virus
period
winter
age
rang
median
pediatr
case
specimen
store
origin
test
pflu
pfast
hologicgenprob
san
diego
ca
rp
biofir
diagnost
inc
salt
lake
citi
ut
thaw
test
ciab
rp
pfast
return
sampl
thaw
test
xpt
addit
archiv
flu
posit
sampl
analyz
assess
assay
perform
strain
viru
addit
sampl
includ
sampl
posit
flua
season
season
season
flub
spring
spring
sampl
equivoc
flua
rp
consid
posit
test
method
specimen
defin
true
posit
posit
two
assay
viral
nucleic
acid
concentr
determin
base
quantifi
control
viral
rna
hologicgenprob
use
either
pflu
pfast
depend
amplif
effici
pflu
detect
flua
flub
rsv
pfast
differenti
briefli
viral
rna
extract
ml
specimen
vtm
along
univers
intern
control
use
easymag
extractor
biomerieux
durham
nc
elut
rna
extract
amplifi
smartcycl
cepheid
carlsbad
ca
per
packag
insert
data
analysi
perform
use
smartcycl
dx
softwar
version
rp
close
system
integr
extract
multiplex
amplif
detect
adenoviru
coronavirus
flua
subtyp
hemagglutinin
gene
flub
human
metapneumoviru
parainfluenza
viru
type
respiratori
syncyti
viru
human
rhinovirusenteroviru
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
filmarray
instrument
result
report
detect
detect
target
invalid
addit
result
equivoc
flua
occur
one
two
flua
specif
target
amplifi
ciab
roch
diagnost
indianapoli
pointofcar
realtim
pcr
perform
coba
liat
instrument
test
use
ml
specimen
vtm
result
may
detect
detect
indetermin
flua
b
assay
invalid
xpt
cepheid
autom
pcr
detect
flua
flub
perform
genexpert
instrument
approxim
ml
specimen
vtm
ad
singleus
dispos
genexpert
cartridg
result
detect
detect
flua
flub
invalid
spc
failur
error
pcc
instrument
error
invalid
error
sampl
method
retest
obtain
valid
result
viral
rna
extract
clinic
specimen
use
easymag
bp
fragment
gene
amplifi
sanger
sequenc
center
function
genom
core
facil
univers
albani
texa
isol
would
amplifi
standard
primer
altern
forward
primer
tgt
aaa
acg
acg
gcc
agt
ttc
crt
crg
gcc
ccc
tc
use
one
patient
sampl
sequenc
holog
sequenc
align
perform
use
mega
version
biodesign
institut
temp
az
probit
analys
limit
detect
probabl
detect
perform
use
spss
version
ibm
armonk
ny
sensit
specif
posit
neg
predict
valu
confid
interv
ci
determin
use
microsoft
excel
redmond
wa
evalu
involv
retrospect
analysi
consecut
nasopharyng
specimen
receiv
laboratori
detect
respiratori
virus
incid
flu
exclus
origin
specimen
test
pflupfast
test
rp
pflu
demonstr
suboptim
perform
circul
strain
sensit
exclud
test
initi
intent
studi
evalu
perform
ciab
specimen
analyz
ciab
xpt
rp
pfast
perform
need
depend
origin
clinic
test
specimen
reproduc
problemat
method
howev
three
specimen
initi
invalid
ciab
six
specimen
produc
instrument
error
xpert
per
cepheid
instrument
error
xpert
may
relat
vtm
sixtyon
specimen
true
posit
tp
flua
ie
posit
two
test
tabl
tp
case
posit
perform
characterist
assay
present
tabl
sensitivityspecif
pfast
rp
ciab
xpt
pflu
circul
strain
respect
posit
predict
valu
assay
good
period
addit
archiv
flu
posit
sampl
analyz
assess
assay
perform
strain
viru
flua
sampl
analyz
five
assay
pfast
exclud
analysi
flub
sampl
appropri
posit
specimen
one
initi
invalid
rp
anoth
three
produc
instrument
error
xpt
two
resolv
repeat
test
sampl
repeat
error
exclud
analysi
xpt
pflu
pfast
ciab
detect
sampl
posit
tabl
wherea
rp
posit
addit
six
rp
posit
specimen
equivoc
flua
posit
sampl
valid
result
xpt
posit
system
five
assay
detect
eight
season
flua
sampl
howev
one
sampl
type
rp
ciab
system
detect
flub
sampl
posit
wherea
pflu
rp
detect
differ
sampl
neg
pflu
rp
one
specimen
becam
neg
upon
freez
thaw
test
xpt
confirm
neg
pflu
ciab
xpt
posit
remain
sampl
sensit
assay
improv
archiv
strain
flu
previou
year
tabl
demonstr
assay
perform
variat
strain
associ
perform
lod
method
six
strain
flu
gener
lod
highli
variabl
viru
strain
assay
tabl
pflu
ciab
lower
lod
compar
rp
xpt
perth
inferior
lod
texa
fact
highest
concentr
viru
avail
log
copi
ml
detect
pflu
convers
pfast
demonstr
lowest
lod
strain
interestingli
inconsist
result
observ
across
broad
rang
dilut
strain
rp
equivoc
call
common
suggest
one
two
flua
target
effici
strain
swiss
strain
pfast
rp
lod
superior
ciab
xpert
pflu
lod
fell
midrang
pflu
ciab
xpt
perform
well
flub
sensit
commerci
assay
highli
variabl
sampl
popul
box
whisker
plot
fig
demonstr
differ
vl
fals
neg
fn
sampl
vs
true
posit
sampl
assay
fn
result
assay
lod
texa
swiss
isol
illustr
dash
line
highest
vl
seen
pflu
fn
sampl
lower
assay
lod
texa
strain
lower
lod
swiss
strain
next
highest
vl
seen
xpt
fn
sampl
case
viru
titer
lower
assay
lod
swiss
strain
viru
titer
lower
lod
texa
strain
ciab
fn
sampl
titer
lod
strain
viru
two
fn
rp
sampl
lod
strain
fn
pfast
sampl
mp
gene
sequenc
variou
histor
isol
flua
virus
analyz
lod
studi
clinic
specimen
suboptim
perform
pflu
align
tabl
although
illustr
region
consid
highli
conserv
includ
recommend
target
region
sequenc
diverg
observ
holog
indic
weak
posit
fals
neg
flua
result
observ
lab
laboratori
due
variant
contain
point
mutat
pflu
probe
bind
region
mutat
primer
bind
region
exact
target
region
use
commerci
test
investig
proprietari
indic
gener
target
region
commerci
assay
somewhat
similar
target
region
tabl
prior
influenza
season
mutat
matrix
gene
affect
perform
molecular
test
observ
isol
case
fals
neg
pflu
result
due
two
point
mutat
assay
probe
bind
region
sinc
probe
primer
bind
region
proprietari
difficult
specul
mutat
affect
probe
bind
base
diverg
histor
sequenc
one
would
expect
mutat
minnesota
strain
strain
interestingli
overmeir
et
al
demonstr
point
mutat
pivot
loss
activ
probe
cemark
assay
qiagen
inde
mutat
seen
virus
mutat
observ
diverg
within
mp
gene
virus
first
report
taiwanes
virus
mutat
affect
recommend
target
region
report
mp
mutat
correl
clade
virus
europ
demonstr
true
usa
uniqu
usa
virus
also
carri
mp
gene
pattern
mp
gene
european
clade
virus
similar
worldwid
major
virus
collect
season
clade
virus
predomin
mani
region
origin
report
usa
isol
septemb
clade
remain
antigen
similar
clade
howev
appear
earli
season
usa
similar
rate
clade
cocircul
virus
quickli
predomin
repres
viru
popul
januari
interestingli
mp
sequenc
obtain
texaslik
strain
obtain
differ
publish
prototyp
sequenc
similar
mp
sequenc
clinic
isol
howev
surpris
given
clade
viru
mp
gene
usa
virus
evolv
similar
virus
respiratori
season
firsttim
report
fals
neg
result
reduc
sensit
commerci
pcr
test
associ
entir
clade
virus
lab
fortun
identifi
problem
earli
octob
routin
interrog
amplif
curv
allow
recognit
three
case
abnorm
curv
suppl
fig
thu
sampl
lab
request
pflu
test
test
pflu
pfast
holog
modifi
pflu
packag
insert
indic
limit
viru
littl
els
warn
custom
fals
believ
phenomenon
restrict
region
hand
cepheid
recogn
issu
made
chang
current
avail
assay
enabl
extend
flu
rsv
coverag
author
institut
receiv
sever
research
grant
abbott
molecular
bd
biomerieux
roch
diagnost
dr
stellrecht
receiv
reimburs
travel
expens
attend
meet
confer
abbott
molecular
quidel
roch
diagnost
studi
sponsor
part
roch
diagnost
corpor
obtain
albani
medic
center
